Evidara unifies real-world evidence, clinical trial intelligence, and genomic data into a single AI reasoning layer — built by a scientist with a decade of translational research, HEOR, and clinical development expertise.
Click any capability to run a live AI analysis — powered by real AI. Enter any drug, disease, or molecule and get structured scientific intelligence in seconds.
Build economic models grounded in real genomic and clinical evidence — not just payer claims data.
Answer complex medical questions with synthesized evidence across literature, trials, and RWD.
Evaluate assets faster with AI-generated target validation, competitive landscape, and trial readouts.
Accelerate hypothesis generation from genomic signals through to clinical validation strategies.
"Most AI tools in pharma are built by people who've never seen a Phase III dataset. Evidara is different — every workflow encodes decade-deep domain knowledge."
Aetion transforms RWD into evidence. Unlearn optimizes trial design. IQVIA owns the data. But none of them start from the biology.
Evidara was built by someone who spent a decade at the bench — interpreting GWAS signals, designing clinical trials, building HEOR models, running CRISPR screens. Every tool was designed to answer: what does a senior scientist actually need to make a confident decision?
The result: an AI platform that doesn't just retrieve data — it reasons across it, at machine speed, on demand.
Schedule a private demo and see how Evidara transforms your drug development pipeline — from genomics to market access, in a single platform.
Enter a drug, disease, molecule, or research question above
and Evidara will run a live AI analysis.